SCHEMBL236146

SCHEMBL236146

C1CN(N2CCOCC2)CCO1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.47
CA12 O43570 5/20 0.42
CA7 P43166 1/20 0.42
CA14 Q9ULX7 1/20 0.42
TTR P02766 1/20 0.42
CA1 P00915 4/20 0.38
CA9 Q16790 4/20 0.38
CA2 P00918 3/20 0.38
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
FAAH O00519 1/20 0.36
PHGDH O43175 1/20 0.36
ALDH2 P05091 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KEAP1 Q14145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19878897 0.96
Hydrochloric Acid SCHEMBL28019904 0.96 MGLL (0.44) MGLLCA12CA7CA14TTR
SCHEMBL6300105 0.89 TSHR (0.43) MGLLCA12CA7CA14TTR
SCHEMBL170249 0.89 TSHR (0.40) MGLLCA12CA7CA14TTR
SCHEMBL5526972 0.86 TSHR (0.44) MGLLCA12CA7CA14TTR
SCHEMBL718510 0.86 TSHR (0.44) MGLLCA12CA7CA14TTR
SCHEMBL1582709 0.86 TSHR (0.44) MGLLCA12CA7CA14TTR
SCHEMBL31348042 0.86 ALDH1A1 (0.44) MGLLCA12CA7CA14TTR
Bicarbonate SCHEMBL27715414 0.83 HSD17B10 (0.48) CA12CA7CA14CA1CA9
Hydrochloric Acid SCHEMBL28974479 0.83 TSHR (0.42) MGLLCA12CA7CA14CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108129713-A Rubber-plastic alloy and preparation method, application is blended in NBR-PVC 江苏骆氏减震件有限公司 2018-06-08 CN claimed
CN-106939089-A A kind of elastomeric material, Preparation Method And The Use 江苏骆氏减震件有限公司 2017-07-11 CN claimed
CN-1656073-A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases NOVARTIS AG (CH) 2005-08-17 CN claimed
EP-4736255-A2 SPIROBISINDANE COPOLYMERS AND METHODS OF MAKING Sepion Technologies, Inc. (US) 2026-05-06 EP disclosed
US-12577412-B2 Corrosion inhibiting coating compositions PRC-DESOTO INTERNATIONAL, INC. (US) 2026-03-17 US disclosed
WO-2025006736-A9 SPIROBISINDANE COPOLYMERS AND METHODS OF MAKING SEPION TECHNOLOGIES, INC. (US) 2025-04-17 WO disclosed
WO-2025006736-A2 SPIROBISINDANE COPOLYMERS AND METHODS OF MAKING SEPION TECHNOLOGIES, INC. (US) 2025-01-02 WO disclosed
CN-118742614-A Dispersion containing conductive polymer, solid electrolytic capacitor, and method for producing same 株式会社力森诺科 2024-10-01 CN disclosed
WO-2024149331-A1 AMINO LIPID COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 深圳深信生物科技有限公司 2024-07-18 WO disclosed
WO-2024137989-A1 SPIROBISINDANE POLYMERS OF INTRINSIC MICROPOROSITY AND METHODS OF MAKING SEPION TECHNOLOGIES, INC. (US) 2024-06-27 WO disclosed
US-20240174631-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING FGF ACTIVITY RECOVERY THERAPEUTICS, INC. 2024-05-30 US disclosed
WO-2003023568-A2 COMPUTATIONAL METHOD FOR DETERMINING ORAL BIOAVAILABILITY PARATEK PHARMACEUTICALS, INC. (US) 2003-03-20 WO disclosed
CN-1045597-C Alkylenediamine derivatives NIPPON CHEMIPHAR CO (JP) 1999-10-13 CN disclosed
US-5944854-A LEUCO DYES DYSTAR TEXTILFARBEN GMBH & CO. (DE) 1999-08-31 US disclosed
US-5696258-A REDUCING TO LEUCO FORM; REOXIDATION DYSTAR TEXTILFARBEN GMBH (DE) 1997-12-09 US disclosed
US-5412104-A Hypotensive and antiviral agents SCHERING CORPORATION (US) 1995-05-02 US disclosed
US-5087671-A Insoluble polymers containing reactive groups THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 1992-02-11 US disclosed
US-4097479-A FROM ORGANIC NITRILE AND AZIDE ANION, AMINE SOLVENT MILES LABORATORIES, INC. (US) 1978-06-27 US disclosed
US-4066637-A BASIC DIAMINOPYRIDINE-(3)-AZO DYESTUFFS CIBA-GEIGY CORPORATION (US) 1978-01-03 US disclosed
US-3931169-A ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174631-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING FGF ACTIVITY FGF1, FGF2, FGFR1 MGLL 2863/4885CA12 3201/4885CA7 4023/4885
US-12577412-B2 Corrosion inhibiting coating compositions MGMT, MBD2, MECP2 MGLL 4147/4885CA12 1685/4885CA7 1576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.